Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

NCT01722305 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
Central Nervous System Lymphoma
Intraocular Lymphoma
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
Recurrent Adult Diffuse Large Cell Lymphoma
Retinal Lymphoma

Interventions

DRUG: Dexamethasone
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
DRUG: Pomalidomide

Sponsor

Mayo Clinic

Collaborators

[object Object]